Scott Minick

Scott Minick has a robust professional background in healthcare and venture capital, currently serving as a Board Member at BPGbio, Inc. since June 2024, and as an Advisor at Alzheon, Inc. since July 2021. Minick has been a Board Member at Beth Israel Deaconess Medical Center since 2012. Furthermore, Minick was a Member of the Board of Trustees at Sierra Nevada College from July 2016 to July 2022, and served as a Venture Partner at ARCH Venture Partners from December 2010 to July 2021. Additional roles include Executive Chairman at Aira from May 2016 to July 2020, Board Member at Chiasma from October 2007 to July 2019, and Board Member at Alzheon, Inc. from 2012 to July 2017. Minick was also the CEO of BIND Therapeutics from January 2010 to March 2015 and Chairman of the Board of Directors at California Pacific Medical Center from 2006 to 2014. Educational credentials include an MBA from Kellogg School of Management at Northwestern University from 1979 to 1981, along with additional studies at UC San Diego.